Brontictuzumab companion diagnostic - OncoMed

Drug Profile

Brontictuzumab companion diagnostic - OncoMed

Alternative Names: NGS assay - OncoMed

Latest Information Update: 17 Jun 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator OncoMed Pharmaceuticals
  • Developer MolecularMD; OncoMed Pharmaceuticals
  • Class Diagnostic agents
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I Haematological malignancies
  • Phase Unknown Solid tumours

Most Recent Events

  • 14 Jun 2014 Investigation in Solid tumours (diagnosis) in USA (unspecified route)
  • 04 Jun 2014 Phase-I clinical trials in Haematological malignancies (diagnosis) in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top